Skip to Main Content

Medtronic plc

MDT Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

$MDT is featured in our Dan Meuser and Shelley Moore Capito strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDT by members of U.S. Congress

Politician Type Traded
Julie Johnson House / D Sale $1,001 - $15,000 Nov 13, 2025
Richard McCormick House / R Purchase $1,001 - $15,000 Nov 05, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 27, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 15, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
George Whitesides House / D Sale $50,001 - $100,000 Mar 24, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Mar 20, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 19, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Emily Randall House / D Sale $1,001 - $15,000 Jan 06, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Sale $1,001 - $15,000 N/A
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Aug 26, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jul 09, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun 18, 2024
John James House / R Sale $1,001 - $15,000 Jun 03, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 13, 2024
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb 09, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan 23, 2024
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Kathy E. Manning House / D Sale $15,001 - $50,000 Dec 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Debbie Dingell House / D Purchase $15,001 - $50,000 Dec 05, 2023
John James House / R Purchase $1,001 - $15,000 Nov 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct 24, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Oct 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep 26, 2023
Pete Ricketts Senate / R Sale (Full) $50,001 - $100,000 Sep 21, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 13, 2023
MDT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MDT holdings by institutional investors

Quarterly net insider trading by MDT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

MDT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

MDT Revenue by Segment or Geography

By Segment
By Geography
MDT Income Statement
MDT Balance Sheet
MDT Cash Flow
U.S. Patents

New MDT patent grants

  • Patent Title: Interconnection of conductor to feedthrough Aug. 08, 2017
  • Patent Title: Frequency based therapy generation Aug. 08, 2017
  • Patent Title: Methods, implantable medical devices, and systems to continue implementing a special mode of operation after experiencing a device reset Aug. 08, 2017
  • Patent Title: Ventricular leadless pacing device mode switching Aug. 08, 2017
  • Patent Title: Dynamic patient-specific filtering of an activity signal within a beating heart Aug. 08, 2017
  • Patent Title: Brain stimulation response profiling Aug. 08, 2017
  • Patent Title: Variation of neural stimulation parameters Aug. 08, 2017
  • Patent Title: Incontinence therapy Aug. 08, 2017
  • Patent Title: Selective termination of stimulation to deliver post-stimulation therapeutic effect Aug. 08, 2017
  • Patent Title: Interventional medical systems and associated tethering assemblies and methods Aug. 08, 2017
  • Patent Title: Annuloplasty ring holder Aug. 08, 2017
  • Patent Title: Introduction of medical lead into patient Aug. 08, 2017
  • Patent Title: Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions Aug. 08, 2017
  • Patent Title: Remote calibration of an implantable patient sensor Aug. 08, 2017
  • Patent Title: Implantable medical device system having implantable cardioverter-defibrillator (icd) system and substernal leadless pacing device Aug. 01, 2017
  • Patent Title: Systems and methods for implanting a medical electrical lead Aug. 01, 2017
  • Patent Title: Therapy system including multiple posture sensors Aug. 01, 2017
  • Patent Title: Patient data display Aug. 01, 2017
  • Patent Title: Atrial arrhythmia detection during intermittent instances of ventricular pacing in a cardiac medical device Aug. 01, 2017
  • Patent Title: Devices and methods for sensing physiological signals during stimulation therapy Aug. 01, 2017
  • Patent Title: Implantable medical device delivery catheter with tether Aug. 01, 2017
  • Patent Title: Fail-safe programming for implantable medical device Jul. 25, 2017
  • Patent Title: Lead delivery device and method Jul. 25, 2017
  • Patent Title: Implantable medical elongated member including intermediate fixation Jul. 25, 2017
  • Patent Title: Modular lead end Jul. 25, 2017
  • Patent Title: Using multiple diagnostic parameters for predicting heart failure events Jul. 25, 2017
  • Patent Title: Multi-staged filtration system for blood fluid removal Jul. 25, 2017
  • Patent Title: Recirculating dialysate fluid circuit for blood measurement Jul. 25, 2017
  • Patent Title: Degassing system for dialysis Jul. 25, 2017
  • Patent Title: Trial stimulation systems Jul. 18, 2017
  • Patent Title: Systems, methods, and interfaces for configuring cardiac therapy Jul. 18, 2017
  • Patent Title: Cardiac resynchronization therapy optimization based on intracardiac impedance and heart sounds Jul. 18, 2017
  • Patent Title: Cortical potential monitoring Jul. 18, 2017
  • Patent Title: Personalized housing for ambulatory infusion device Jul. 18, 2017
  • Patent Title: Dual flow sorbent cartridge Jul. 18, 2017
  • Patent Title: Sorbent cartridge to measure solute concentrations Jul. 18, 2017
  • Patent Title: Sleep stage detection Jul. 18, 2017
  • Patent Title: Criteria for optimal electrical resynchronization during biventricular pacing Jul. 11, 2017
  • Patent Title: Combination of feedback on mechanical and electrical resynchronization to select therapy parameters Jul. 11, 2017
  • Patent Title: Methods and devices for inhibiting tissue growth from restricting a strain relief loop of an implantable medical lead Jul. 11, 2017
  • Patent Title: Chronic ph or electrolyte monitoring Jul. 11, 2017
  • Patent Title: Artificial scab for use in an airway Jul. 11, 2017
  • Patent Title: Techniques for minimizing current drain in an implantable medical device Jul. 04, 2017
  • Patent Title: Automated verification of mri compatibility of active implantable medical device Jul. 04, 2017
  • Patent Title: Dual chamber timing for leadless pacemakers using infrequent atrial signals and ventricular contractions Jul. 04, 2017
  • Patent Title: Transvenous active fixation lead system Jul. 04, 2017
  • Patent Title: Titanium alloy contact ring element having low modulus and large elastic elongation Jul. 04, 2017
  • Patent Title: Segmented transcatheter valve prosthesis having an unsupported valve segment Jul. 04, 2017
  • Patent Title: Vibration sensitive ablation device and method Jul. 04, 2017
  • Patent Title: Optical sensor system and measurement method Jul. 04, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to MDT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
MDT News

Recent insights relating to MDT

CNBC Recommendations

Recent picks made for MDT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDT

MDT Analyst Ratings

MDT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDT stock a Buy, Sell, or Hold?

  • What is the price target for $MDT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDT Top Shareholders
Shareholder
Shares Held
MDT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDT stock?

  • Who owns the most shares of $MDT stock?

  • What funds own $MDT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDT

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Back To Top